Status:
TERMINATED
Treatment of Schizoaffective Disorder Using Mifepristone
Lead Sponsor:
Stanford University
Collaborating Sponsors:
Pritzker Family Foundation
Conditions:
Psychotic Disorders
Depressive Disorder, Major
Eligibility:
All Genders
18-75 years
Phase:
PHASE2
PHASE3
Brief Summary
This study tests the hypothesis that mifepristone will diminish cognitive distortion and alleviate psychosis in patients with schizoaffective disorder.
Detailed Description
You are invited to participate in a research study which evaluates the effectiveness of mifepristone (RU 486) in rapidly reducing the symptoms associated with schizoaffective disorder. Our group belie...
Eligibility Criteria
Inclusion
- The subjects will be 30 inpatients or outpatients with schizoaffective disorder.
Exclusion
- Subjects must be between the ages of eighteen and seventy-five without major medical problems.
Key Trial Info
Start Date :
April 1 1998
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
May 1 2009
Estimated Enrollment :
12 Patients enrolled
Trial Details
Trial ID
NCT00725270
Start Date
April 1 1998
End Date
May 1 2009
Last Update
March 24 2017
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Stanford University School of Medicine
Stanford, California, United States, 94305